Existence and pharmacological properties of dopamine D4 receptors in guinea pig vas deferens

European Journal of Pharmacology

Volumn 374, Issue 2, 1999, Pages 255-261

  Morishita, Hideji ^a   Katsuragi, Takeshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

ATP; Dopamine; Dopamine D4 receptor; Vas deferens, guinea pig

Indexed keywords

8 METHYL 6 (4 METHYL 1 PIPERAZINYL) 11H PYRIDO[2,3B] 1,4 BENZODIAZEPINE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; NORADRENALIN; PRAZOSIN; RACLOPRIDE; SPIPERONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; MALE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; VAS DEFERENS; VASOCONSTRICTION;

ANIMALS; CARDIOTONIC AGENTS; DOPAMINE; DRUG INTERACTIONS; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RECEPTORS, DOPAMINE D2; VAS DEFERENS;

EID: 0033065753     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00312-X     Document Type: Article

References (22)

1. Bühler H.U., Da Prada M., Haefely W., Picotti G.B. Plasma adrenaline, noradrenaline and dopamine in man and different animal species. J. Physiol. 276:1978;311-320.
2. Burnstock G. The Fifth Heymans Memorial Lecture-Ghent, February 17, 1990 (co-transmission). Arch. Int. Pharmacodyn. 304:1990;7-33.
3. 2x-purinoceptor? Gen. Pharmacol. 16:1985;433-440.
4. Coward D.M. General pharmacology of clozapine. Br. J. Psychiatry. 160(17):1992;5-11. suppl.
5. Fedan J.S., Hogaboom G.K., O'Donnell J.P., Colby J., Westfall D.P. Contribution by purines to the neurogenic response of the vas deferens of the guinea pig. Eur. J. Pharmacol. 69:1981;41-53.
6. 3), an ATP antagonist, on response of the smooth muscle of the guinea pig vas deferens to ATP and related nucleotides. Eur. J. Pharmacol. 85:1982;277-290.
7. 1 receptor on the sympathetic nerve endings in the guinea pig vas deferens. Eur. J. Pharmacol. 328:1997;229-234.
8. Holck M.I., Marks B.H. Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoceptor responsiveness in guinea pig vas deferens. J. Pharmacol. Exp. Ther. 205:1978;104-117.
9. Kažić T., Milosavljević D. Interaction between adenosine triphosphate and noradrenaline in the isolated vas deferens of the guinea pig. Br. J. Pharmacol. 71:1980;93-98.
10. Liégeois J.-F., Bruhwyler J., Damas J., Nguyen T.P., Chleide E., Mercier M., Rogister F., Delarge J. New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study. J. Med. Chem. 36:1993;2107-2114.
11. 4 receptor. Eur. J. Pharmacol. 273:1995;R1-R3.
12. 2 receptor as an enhancer of contractile response in vas deferens. Eur. J. Pharmacol. 344:1998;223-229.
13. Seeman P., Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
14. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
15. 2 Dopamine Receptor Interactions. Academic Press, London, pp. 1-21.
16. Sneddon P., Westfall D.P., Fedan J.S. Co-transmitters in the motor nerves of the guinea pig vas deferens: electrophysiological evidence. Science. 218:1982;693-695.
17. Sokoloff P., Schwartz J.C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
18. Stanaszek W.F., Kellerman D., Brogden R.N., Romankiewicz J.A. Prazosin update; a review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs. 25:1983;339-384.
19. 4 receptors: curiouser and curiouser. Trends Pharmacol. Sci. 15:1994;317-319.
20. Tayo F.M. Occurrence of excitatory dopaminoceptors in the rat and guinea pig vas deferens. Clin. Exp. Pharmacol. Physiol. 6:1979;275-279.
21. Van Loon G.R. Plasma dopamine: regulation and significance. Fed. Proc. 42:1983;3012-3018.
22. Witt P.A., Kramer T.H., Burks T.F. Norepinephrine and ATP are synergistic in the mouse vas deferens preparation. Eur. J. Pharmacol. 204:1991;149-155.